A Randomized, Open-label, Cross-over Study to Evaluate Patient Preferences for Eucreas Versus Victoza as add-on to Metformin in Type 2 Diabetes Mellitus Patients Who Did Not Have Adequate Glycaemic Control With Metformin.

Trial Profile

A Randomized, Open-label, Cross-over Study to Evaluate Patient Preferences for Eucreas Versus Victoza as add-on to Metformin in Type 2 Diabetes Mellitus Patients Who Did Not Have Adequate Glycaemic Control With Metformin.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Mar 2017

At a glance

  • Drugs Liraglutide; Metformin; Vildagliptin/metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms PREFER
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Mar 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2011-003818-16).
    • 01 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top